METHYLPREDNISOLONE VERSUS DEXAMETHASONE FOR TREATMENT OF SEVERE OR CRITICAL COVID-19: A QUASI-EXPERIMENTAL STUDY (MD TREAT)

METHYLPREDNISOLONE VERSUS DEXAMETHASONE FOR TREATMENT OF SEVERE OR CRITICAL COVID-19: A QUASI-EXPERIMENTAL STUDY (MD TREAT)

Intro: Dexamethasone, a corticosteroid, was recently demonstrated to be the only medication capable of reducing mortality in severe COVID disease in the UK's Recovery Trial. There is a need to compare different steroids because it is well recognised that different corticosteroids have varied ph...

Full description

Bibliographic Details
Main Authors: N. Nasir, S. Fatima, S. Awan, M. Zakariya, A. Arshad, F. Khalid, M. Aqeel
Format: Article
Language:English
Published: Elsevier 2023-05-01
Series:International Journal of Infectious Diseases
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971223005039

Similar Items

Similar Items